GE Healthcare TiO2 Mag Sepharose
Designed for enrichment of phosphopeptides from tryptic digested protein samples. GE Healthcare TiO2 Mag Sepharose magnetic beads are based on titanium dioxide chromatography and are designed to simplify capture and enrichment of phosphopeptides.
Manufacturer: GE Healthcare 28951377
TiO2 Mag Sepharose has high affinity for phosphopeptides and is an efficient method for enrichment of phosphopeptides from complex samples. The magnetic bead format improves ease-of-use in sample preparation and has excellent properties for small-scale experiments. The high density beads allows rapid capture by magnetic devices with high visibility to ensure reliable collection of all bound target peptides.
- Magnetic beads for selective capture and enrichment of phosphopeptides
- Easy to use - visible and dense magnetic beads
- Simple protocol with elution conditions optimized for MS analysis
- Parallel sample handling when used with MagRack 6 separation tool - process up to six samples in less than one hour
This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.
|TiO2 Mag Sepharose|
|37 to 100μm|
|4° to 30°C (use at room temperature)|
|Used for selective capture and enrichment of Phosphopeptides, for biomarker research|
|Paramagnetic spherical, highly cross linked agarose particles|
|4 x 500μL|
|20% ethanol storage solution|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok